Search results for: 'quantitative dsp analysis research'

This study explores the transformative potential of organoid technologies in advancing cancer research, precision medicine, and drug discovery. Organoids—3D cell culture systems derived from patient tumors—preserve tumor heterogeneity and provide physiologically relevant models for studying cancer biology, therapeutic response, and resistance mecha...

The SCOPE Summit 2026, held in Orlando, Florida, from February 2 to 5, 2026, highlighted the dominance of small- to mid-segment companies and specialized CROs focusing on specific therapy areas or aspects of clinical trials, such as bioanalysis. With more than 4,000 attendees, 630 speakers, and 300 exhibitors, SCOPE 2026 reinforced its position as ...

As the industry continues to innovate across novel small- and large-molecule therapies, including RNA-targeted small molecules, cell and gene therapies, and mRNA therapies, pharma sponsors increasingly rely on partners for technology access, database generation and analysis, and preclinical and clinical research.These disruptions continue to drive ...

09 Sep 2025  |  Global  |  Technology Research

Mixed Reality in Healthcare, Global, 2025–2029

Mixed Reality in Healthcare Is Driving Transformational Growth Through Medical Education, Emerging Growth Opportunities, Global Ecosystems, and Advanced Technology Analysis

Infographics

×

Mixed reality (MR) merges real and virtual elements to create interactive environments. Workforce shortages, rising training needs, patient engagement gaps, and the shift toward decentralized care are driving demand for immersive technologies in healthcare. By blending virtual and augmented reality, MR enables learners to practice complex clinical ...

The Healthcare IT Outlook 2026 examines the industry’s transition from experimentation to enterprise-scale execution, as artificial intelligence (AI), workflow orchestration, and platform consolidation reshape clinical, operational, and financial workflows. Following several years of pilot-led innovation, 2026 marks a pivotal inflection point where...

As the healthcare industry shifts from a fee-for-service to a fee-for-value model, value-based reimbursement is becoming the standard for accountable care organizations (ACOs), independent physician practices, and non-ACO entities. This transition underscores the essential role of clinical documentation integrity (CDI) specialists, medical coders, ...

This report examines how decentralized clinical trials (DCTs), enabled by blockchain, digital twins, and artificial intelligence, are reshaping global clinical research. It traces the shift from site-centric to patient-centric models and quantifies the growing scale, globalization, and complexity of clinical trials that make decentralization necess...

This Frost Radar™ analyzes the clinical ambient AI solutions that enable clinicians to improve their efficiency at the point of care. AI scribe capability has become the baseline market requirement, eliminating it as a differentiator and pushing vendors to compete on higher-order clinical and financial workflow integration. These capabilities inclu...

The report explores the transformation of obesity care from generalized BMI-based treatment to AI-enabled precision metabolic management. The study highlights how obesity is increasingly recognized as a heterogeneous, multi-pathway disease influenced by genetic, neurobehavioral, metabolic, and environmental factors, requiring personalized therapeut...